During the past decade, Carey Chronis, MD conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Carey Chronis, MD" are "Pneumococcal Disease" (1 trials) and "Respiratory Tract Infection" (1 trials). Many other conditions were trialed in "Carey Chronis, MD" in a lesser frequency.

Most popular intervention types in "Carey Chronis, MD" are "Biological" (2 trials). Other intervention types were less common.

The name of intervention was led by "13-valent pneumococcal conjugate vaccine" (1 trials), "20-valent pneumococcal conjugate vaccine" (1 trials), "Placebo" (1 trials) and "RSVpreF" (1 trials). Other intervention names were less common.

The vast majority of trials in "Carey Chronis, MD" are 1 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Carey Chronis, MD". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Carey Chronis, MD, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Carey Chronis, MD, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".